yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. .
![save as pdf](/b98584f181.site.internapcdn.net/tmpl/v5/img/1x1.gif)
boston cio of the year® orbie® awards .
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
-
.
OFF DEAL
218 Used Today